Skip to main content
. 2021 Apr 6;13(7):1744. doi: 10.3390/cancers13071744
APPs Acute phase proteins
C4 Complement component 4
cC3 Cleaved caspase-3
DE Differentially expressed
EMF Electromagnetic field
FC Fold change
H&E Hematoxylin and eosin
HER2 Human epidermal receptor growth factor receptor 2
Hsp70 Heat shock protein 70
IHC Immunohistochemistry
LFQ Label-free quantification
mEHT Modulated electro-hyperthermia
mRNA Messenger ribonucleic acid
MS Mass spectrometry
NGS RNA seq Next-generation sequencing ribonucleic acid sequencing
RF Radio frequency
RT-qPCR Real-time quantitative polymerase chain reaction
TDR Tissue damage ratio
TNBC Triple-negative breast cancer